Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

An RNA-seq study in Friedreich ataxia patients identified hsa-miR-148a-3p as a putative prognostic biomarker of the disease.

Vancheri, Chiara; Quatrana, Andrea; Morini, Elena; Mariotti, Caterina; Mongelli, Alessia; Fichera, Mario; Rufini, Alessandra; Condò, Ivano; Testi, Roberto; Novelli, Giuseppe; Malisan, Florence; Amati, Francesca.

Hum Genomics ; 18(1): 50, 2024 May 22.

Artículo en Inglés | MEDLINE | ID: mdl-38778374

2.

Hsa-miR223-3p circulating level is upregulated in Friedreich's ataxia and inversely associated with HCLS1 associated protein X-1, HAX-1.

Quatrana, Andrea; Morini, Elena; Tiano, Francesca; Vancheri, Chiara; Panarello, Luca; Romano, Silvia; Marcotulli, Christian; Casali, Carlo; Mariotti, Caterina; Mongelli, Alessia; Fichera, Mario; Rufini, Alessandra; Condò, Ivano; Novelli, Giuseppe; Testi, Roberto; Amati, Francesca; Malisan, Florence.

Hum Mol Genet ; 31(12): 2010-2022, 2022 06 22.

Artículo en Inglés | MEDLINE | ID: mdl-35015850

3.

Interferon Gamma Enhances Cytoprotective Pathways via Nrf2 and MnSOD Induction in Friedreich's Ataxia Cells.

Luffarelli, Riccardo; Panarello, Luca; Quatrana, Andrea; Tiano, Francesca; Fortuni, Silvia; Rufini, Alessandra; Malisan, Florence; Testi, Roberto; Condò, Ivano.

Int J Mol Sci ; 24(16)2023 Aug 11.

Artículo en Inglés | MEDLINE | ID: mdl-37628866

4.

Frataxin deficiency in Friedreich's ataxia is associated with reduced levels of HAX-1, a regulator of cardiomyocyte death and survival.

Tiano, Francesca; Amati, Francesca; Cherubini, Fabio; Morini, Elena; Vancheri, Chiara; Maletta, Sara; Fortuni, Silvia; Serio, Dario; Quatrana, Andrea; Luffarelli, Riccardo; Benini, Monica; Alfedi, Giulia; Panarello, Luca; Rufini, Alessandra; Toschi, Nicola; Frontali, Marina; Romano, Silvia; Marcotulli, Christian; Casali, Carlo; Gioiosa, Silvia; Mariotti, Caterina; Mongelli, Alessia; Fichera, Mario; Condò, Ivano; Novelli, Giuseppe; Testi, Roberto; Malisan, Florence.

Hum Mol Genet ; 29(3): 471-482, 2020 02 01.

Artículo en Inglés | MEDLINE | ID: mdl-31943004

5.

Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.

Alfedi, Giulia; Luffarelli, Riccardo; Condò, Ivano; Pedini, Giorgia; Mannucci, Liliana; Massaro, Damiano S; Benini, Monica; Toschi, Nicola; Alaimo, Giorgia; Panarello, Luca; Pacini, Laura; Fortuni, Silvia; Serio, Dario; Malisan, Florence; Testi, Roberto; Rufini, Alessandra.

Mov Disord ; 34(3): 323-334, 2019 03.

Artículo en Inglés | MEDLINE | ID: mdl-30624801

6.

Src inhibitors modulate frataxin protein levels.

Cherubini, Fabio; Serio, Dario; Guccini, Ilaria; Fortuni, Silvia; Arcuri, Gaetano; Condò, Ivano; Rufini, Alessandra; Moiz, Shadman; Camerini, Serena; Crescenzi, Marco; Testi, Roberto; Malisan, Florence.

Hum Mol Genet ; 24(15): 4296-305, 2015 Aug 01.

Artículo en Inglés | MEDLINE | ID: mdl-25948553

7.

Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells.

Rufini, Alessandra; Cavallo, Francesca; Condò, Ivano; Fortuni, Silvia; De Martino, Gabriella; Incani, Ottaviano; Di Venere, Almerinda; Benini, Monica; Massaro, Damiano Sergio; Arcuri, Gaetano; Serio, Dario; Malisan, Florence; Testi, Roberto.

Neurobiol Dis ; 75: 91-9, 2015 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-25549872

8.

Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model.

Tomassini, Barbara; Arcuri, Gaetano; Fortuni, Silvia; Sandi, Chiranjeevi; Ezzatizadeh, Vahid; Casali, Carlo; Condò, Ivano; Malisan, Florence; Al-Mahdawi, Sahar; Pook, Mark; Testi, Roberto.

Hum Mol Genet ; 21(13): 2855-61, 2012 Jul 01.

Artículo en Inglés | MEDLINE | ID: mdl-22447512

9.

Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia.

Rufini, Alessandra; Fortuni, Silvia; Arcuri, Gaetano; Condò, Ivano; Serio, Dario; Incani, Ottaviano; Malisan, Florence; Ventura, Natascia; Testi, Roberto.

Hum Mol Genet ; 20(7): 1253-61, 2011 Apr 01.

Artículo en Inglés | MEDLINE | ID: mdl-21216878

10.

Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxin.

Condò, Ivano; Malisan, Florence; Guccini, Ilaria; Serio, Dario; Rufini, Alessandra; Testi, Roberto.

Hum Mol Genet ; 19(7): 1221-9, 2010 Apr 01.

Artículo en Inglés | MEDLINE | ID: mdl-20053667

11.

Drug Repositioning in Friedreich Ataxia.

Rufini, Alessandra; Malisan, Florence; Condò, Ivano; Testi, Roberto.

Front Neurosci ; 16: 814445, 2022.

Artículo en Inglés | MEDLINE | ID: mdl-35221903

12.

Acetylation suppresses the proapoptotic activity of GD3 ganglioside.

Malisan, Florence; Franchi, Luigi; Tomassini, Barbara; Ventura, Natascia; Condò, Ivano; Rippo, Maria Rita; Rufini, Alessandra; Liberati, Laura; Nachtigall, Claudia; Kniep, Bernhard; Testi, Roberto.

J Exp Med ; 196(12): 1535-41, 2002 Dec 16.

Artículo en Inglés | MEDLINE | ID: mdl-12486096

13.

Hyaluronic Acid (HA), Platelet-Rich Plasm and Extracorporeal Shock Wave Therapy (ESWT) promote human chondrocyte regeneration in vitro and ESWT-mediated increase of CD44 expression enhances their susceptibility to HA treatment.

Vetrano, Mario; Ranieri, Danilo; Nanni, Monica; Pavan, Antonio; Malisan, Florence; Vulpiani, Maria Chiara; Visco, Vincenzo.

PLoS One ; 14(6): e0218740, 2019.

Artículo en Inglés | MEDLINE | ID: mdl-31251756

14.

Ceramide catabolism critically controls survival of human dendritic cells.

Franchi, Luigi; Malisan, Florence; Tomassini, Barbara; Testi, Roberto.

J Leukoc Biol ; 79(1): 166-72, 2006 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-16244104

15.

E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia.

Benini, Monica; Fortuni, Silvia; Condò, Ivano; Alfedi, Giulia; Malisan, Florence; Toschi, Nicola; Serio, Dario; Massaro, Damiano Sergio; Arcuri, Gaetano; Testi, Roberto; Rufini, Alessandra.

Cell Rep ; 18(8): 2007-2017, 2017 02 21.

Artículo en Inglés | MEDLINE | ID: mdl-28228265

16.

Extracorporeal Shock Wave Treatment (ESWT) enhances the in vitro-induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs).

Leone, Laura; Raffa, Salvatore; Vetrano, Mario; Ranieri, Danilo; Malisan, Florence; Scrofani, Cristina; Vulpiani, Maria Chiara; Ferretti, Andrea; Torrisi, Maria Rosaria; Visco, Vincenzo.

Oncotarget ; 7(6): 6410-23, 2016 Feb 09.

Artículo en Inglés | MEDLINE | ID: mdl-26843618

17.

GD3 ganglioside and apoptosis.

Malisan, Florence; Testi, Roberto.

Biochim Biophys Acta ; 1585(2-3): 179-87, 2002 Dec 30.

Artículo en Inglés | MEDLINE | ID: mdl-12531552

18.

Calnexin suppresses GD3 synthase-induced apoptosis.

Tomassini, Barbara; Malisan, Florence; Franchi, Luigi; Nicolò, Chiara; Calvo, Gloria Brea; Saito, Takashi; Testi, Roberto.

FASEB J ; 18(13): 1553-5, 2004 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-15319364

19.

Mitochondrial lipids as apoptosis regulators.

Malisan, Florence; Testi, Roberto.

Curr Med Chem ; 10(16): 1573-80, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-12871128

20.

GD3 in cellular ageing and apoptosis.

Malisan, Florence; Testi, Roberto.

Exp Gerontol ; 37(10-11): 1273-82, 2002.

Artículo en Inglés | MEDLINE | ID: mdl-12470841

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar:

An RNA-seq study in Friedreich ataxia patients identified hsa-miR-148a-3p as a putative prognostic biomarker of the disease.

Hsa-miR223-3p circulating level is upregulated in Friedreich's ataxia and inversely associated with HCLS1 associated protein X-1, HAX-1.

Interferon Gamma Enhances Cytoprotective Pathways via Nrf2 and MnSOD Induction in Friedreich's Ataxia Cells.

Frataxin deficiency in Friedreich's ataxia is associated with reduced levels of HAX-1, a regulator of cardiomyocyte death and survival.

Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.

Src inhibitors modulate frataxin protein levels.

Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells.

Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model.

Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia.

Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxin.

Drug Repositioning in Friedreich Ataxia.

Acetylation suppresses the proapoptotic activity of GD3 ganglioside.

Hyaluronic Acid (HA), Platelet-Rich Plasm and Extracorporeal Shock Wave Therapy (ESWT) promote human chondrocyte regeneration in vitro and ESWT-mediated increase of CD44 expression enhances their susceptibility to HA treatment.

Ceramide catabolism critically controls survival of human dendritic cells.

E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia.

Extracorporeal Shock Wave Treatment (ESWT) enhances the in vitro-induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs).

GD3 ganglioside and apoptosis.

Calnexin suppresses GD3 synthase-induced apoptosis.

Mitochondrial lipids as apoptosis regulators.

GD3 in cellular ageing and apoptosis.